# NSCLC Isotoxic Hypofractionated Chemoradiotherapy

> **NCT03606239** · NA · UNKNOWN · sponsor: **The Second Hospital of Hebei Medical University** · enrollment: 30 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **RADIATION:** isotoxic hypofractionated group

## Key facts

- **NCT ID:** NCT03606239
- **Lead sponsor:** The Second Hospital of Hebei Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-01
- **Primary completion:** 2024-02-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03606239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03606239, "NSCLC Isotoxic Hypofractionated Chemoradiotherapy". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03606239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*